Scancell CFO to step down as cancer immunotherapy developer names interim replacement

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), th cancer immunotherapy developer, has named David Schilansky as financial adviser and interim chief...